Brokerages expect Colfax Corp (NYSE:CFX) to post earnings of $0.46 per share for the current quarter, Zacks reports. Seven analysts have provided estimates for Colfax’s earnings. The highest EPS estimate is $0.52 and the lowest is $0.37. Colfax also reported earnings per share of $0.46 in the same quarter last year. The firm is scheduled to issue its next quarterly earnings results on Thursday, February 1st.
On average, analysts expect that Colfax will report full year earnings of $1.72 per share for the current financial year, with EPS estimates ranging from $1.69 to $1.75. For the next fiscal year, analysts forecast that the business will post earnings of $2.11 per share, with EPS estimates ranging from $2.07 to $2.15. Zacks’ EPS calculations are an average based on a survey of sell-side research analysts that follow Colfax.
Colfax (NYSE:CFX) last posted its quarterly earnings results on Monday, November 6th. The industrial products company reported $0.42 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.42. The business had revenue of $844.50 million during the quarter, compared to the consensus estimate of $901.09 million. Colfax had a return on equity of 6.26% and a net margin of 4.89%. The company’s revenue for the quarter was up 10.2% compared to the same quarter last year. During the same period last year, the firm earned $0.39 earnings per share.
A number of equities analysts recently commented on the company. Zacks Investment Research upgraded Colfax from a “hold” rating to a “strong-buy” rating and set a $47.00 price target for the company in a research note on Tuesday. Stifel Nicolaus reiterated a “buy” rating and issued a $44.00 price target on shares of Colfax in a research note on Monday, December 11th. Oppenheimer reiterated a “hold” rating on shares of Colfax in a research note on Thursday, November 30th. Longbow Research upgraded Colfax from a “neutral” rating to a “buy” rating in a research note on Tuesday, November 21st. Finally, Royal Bank of Canada reissued a “buy” rating and issued a $44.00 target price on shares of Colfax in a report on Tuesday, November 7th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $45.80.
Colfax (NYSE CFX) traded up $0.35 during trading hours on Wednesday, reaching $41.76. The company had a trading volume of 375,354 shares, compared to its average volume of 766,408. The firm has a market capitalization of $5,140.00, a P/E ratio of 33.68, a price-to-earnings-growth ratio of 1.59 and a beta of 1.26. Colfax has a fifty-two week low of $33.31 and a fifty-two week high of $43.29. The company has a quick ratio of 1.47, a current ratio of 1.80 and a debt-to-equity ratio of 0.38.
In other Colfax news, EVP Daniel A. Pryor sold 53,333 shares of the firm’s stock in a transaction dated Tuesday, December 19th. The shares were sold at an average price of $38.15, for a total value of $2,034,653.95. Following the transaction, the executive vice president now owns 93,557 shares of the company’s stock, valued at $3,569,199.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 10.60% of the company’s stock.
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Toronto Dominion Bank bought a new stake in shares of Colfax during the second quarter valued at approximately $118,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Colfax by 10.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,533 shares of the industrial products company’s stock valued at $139,000 after buying an additional 323 shares during the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of Colfax by 7.3% during the second quarter. The Manufacturers Life Insurance Company now owns 3,688 shares of the industrial products company’s stock valued at $145,000 after buying an additional 251 shares during the last quarter. FNY Managed Accounts LLC bought a new stake in shares of Colfax during the third quarter valued at approximately $160,000. Finally, Valeo Financial Advisors LLC bought a new stake in shares of Colfax during the third quarter valued at approximately $177,000. 74.86% of the stock is currently owned by hedge funds and other institutional investors.
WARNING: This piece of content was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/05/brokerages-expect-colfax-corp-cfx-will-post-earnings-of-0-46-per-share.html.
Colfax Company Profile
Colfax Corporation is an industrial manufacturing and engineering company. The Company provides air and gas handling, and fabrication technology products and services. The Company’s segments include Air and Gas handling, and Fabrication Technology. The Air and Gas Handling segment supplies a range of gas handling products, including heavy-duty centrifugal and axial fans, rotary heat exchangers, gas compressors, pumps and certain related products, as well as aftermarket services.
Get a free copy of the Zacks research report on Colfax (CFX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Colfax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax and related companies with MarketBeat.com's FREE daily email newsletter.